• New Chromabond® Drug Ii

Chromatography

New Chromabond® Drug Ii

May 15 2007

Macherey Nagel GmbH introduces a specific cartridge for solid phase extraction for enrichment of THC (tetrahydrocannabinol) and THC-derivates from blood or urine. The determination of tetrahydrocannabinol and its metabolites is an important procedure in analysis of drugs of abuse and is offered as standard routine method by many laboratories. After enrichment of the analytes respectively pre-cleaning of the sample by SPE subsequent identification by GC/MS is proceeded.

CHROMABOND® Drug II contains a bifunctional adsorbent material, consisting from a strong anion exchanger (SAX, quaternary amine) and C8 modified silica. Two primary retention mechanisms facilitate the use of very strong interferant eluting solvents resulting in very pure extracts especially from heavily matrix loaded samples like urine, plasma, serum or whole blood.

Already available from Macaherey Nagel is CHROMABOND® Drug a SPE-cartridge for enrichment of acidic, neutral and basic drugs. By introducing CHROMABOND® Drug II the scope of SPE products for drug analysis is widened by the important group of THCs.

Digital Edition

Lab Asia 31.3 June 2024

June 2024

Chromatography Articles - Enhancing HPLC Field Service with fast-response, non-invasive flowmeters Mass Spectrometry & Spectroscopy Articles - UV-Vis and fluorescence spectroscopy illumina...

View all digital editions

Events

INTERPHEX Week

Jun 26 2024 Tokyo, Japan

Asia Labex

Jul 03 2024 Gandhinagar, India

EuCheMS Chemistry Congress

Jul 07 2024 Dublin, Ireland

HPLC 2024

Jul 20 2024 Denver, CO, USA

ICMGP 2024

Jul 21 2024 Cape Town, South Africa

View all events